GnRH-I is a small 10 amino acid long peptide (decapeptide) from the hypothalamus, acts at the hypophysis to cause an increase in release of biologically active Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) in the blood.
CAT No: R1393
Gonadotropin-Releasing Hormone I (GnRH-I) is a decapeptide neurohormone that plays a pivotal role in the regulation of vertebrate reproductive physiology. Synthesized in the hypothalamus, GnRH-I is responsible for stimulating the anterior pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby orchestrating downstream events in the hypothalamic-pituitary-gonadal (HPG) axis. Its highly conserved structure and central regulatory function have made it a cornerstone molecule in reproductive endocrinology, neurobiology, and peptide signaling research. The unique biochemical properties and receptor specificity of GnRH-I have driven its widespread adoption in both fundamental and applied scientific investigations.
Endocrine research: GnRH-I is extensively utilized in studies focused on the mechanisms controlling reproductive hormone release. By serving as a model ligand for the GnRH receptor, it enables precise dissection of signal transduction pathways within pituitary gonadotrophs. Researchers frequently employ it to probe the dynamics of LH and FSH secretion, investigate feedback regulation within the HPG axis, and elucidate the molecular basis of neuroendocrine integration. Its use supports the development of experimental models for understanding reproductive disorders and the physiological consequences of altered hormone signaling.
Peptide receptor studies: The decapeptide is a valuable tool for characterizing the pharmacology and molecular biology of GnRH receptors. Through binding assays, structure-activity relationship analyses, and receptor mutagenesis experiments, GnRH-I facilitates the identification of receptor subtypes, mapping of ligand binding domains, and elucidation of downstream signaling cascades. These studies provide critical insights into receptor activation, desensitization, and internalization, informing both basic research and the rational design of receptor modulators.
Peptide synthesis and analog development: GnRH-I serves as a reference standard for the synthesis and evaluation of peptide analogs with modified activity profiles. Its well-characterized sequence and bioactivity make it an essential benchmark for optimizing synthetic methodologies, assessing peptide stability, and evaluating structure-function relationships. Researchers leverage it to develop novel agonists, antagonists, and peptidomimetics aimed at modulating GnRH receptor function in diverse experimental contexts.
Cell signaling investigations: The peptide is instrumental in delineating intracellular signaling networks initiated by GnRH receptor activation. By applying GnRH-I to cultured pituitary or heterologous cell systems, scientists can monitor rapid changes in second messenger pathways, such as calcium mobilization, protein kinase activation, and gene transcription events. These studies enhance understanding of how neuropeptide signals are transduced into cellular responses, supporting broader research into G protein-coupled receptor (GPCR) biology.
Comparative endocrinology: GnRH-I is frequently employed in cross-species analyses to examine evolutionary conservation and divergence of reproductive regulatory mechanisms. Its application in vertebrate model organisms, including fish, amphibians, birds, and mammals, allows for the comparative mapping of GnRH signaling pathways and receptor distribution. Such investigations contribute to a comprehensive understanding of reproductive axis evolution and the adaptive significance of neuroendocrine control across taxa.
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More